Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
ACS Medicinal Chemistry Letters
|
July 26, 2017
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C Lechtenberg, Peter D Mace, E Hampton Sessions, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2016
Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability
Erika J Olson, Bernhard C Lechtenberg, Chunxia Zhao, et al.
The Journal of Biological Chemistry
|
June 17, 2021
A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain
Taylor P Light, Maricel Gomez-Soler, Zichen Wang, et al.
European Journal of Medicinal Chemistry
|
November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist
Maricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Life Science Alliance
|
April 1, 2025
The RBR E3 ubiquitin ligase HOIL-1 can ubiquitinate diverse non-protein substrates in vitro
Xiangyi S Wang, Jenny Jiou, Anthony Cerra, et al.
European Journal of Medicinal Chemistry
|
March 25, 2024
Lipidation and PEGylation Strategies to Prolong the <i>in Vivo</i> Half-Life of a Nanomolar EphA4 Receptor Antagonist
Maricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Nature Communications
|
June 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling
Michael J Roy, Minglyanna G Surudoi, Ashleigh Kropp, et al.
Redox Biology
|
December 6, 2022
Design and characterization of a heterobifunctional degrader of KEAP1
Hao Chen, Nghi H Nguyen, Charlene M Magtoto, et al.
Nature
|
April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissues
Marco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Frontiers in Chemistry
|
May 2, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
Dale J Calleja, Nathan Kuchel, Bernadine G C Lu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
ACS Medicinal Chemistry Letters
|
July 26, 2017
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C Lechtenberg, Peter D Mace, E Hampton Sessions, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2016
Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability
Erika J Olson, Bernhard C Lechtenberg, Chunxia Zhao, et al.
The Journal of Biological Chemistry
|
June 17, 2021
A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain
Taylor P Light, Maricel Gomez-Soler, Zichen Wang, et al.
European Journal of Medicinal Chemistry
|
November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist
Maricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Life Science Alliance
|
April 1, 2025
The RBR E3 ubiquitin ligase HOIL-1 can ubiquitinate diverse non-protein substrates in vitro
Xiangyi S Wang, Jenny Jiou, Anthony Cerra, et al.
European Journal of Medicinal Chemistry
|
March 25, 2024
Lipidation and PEGylation Strategies to Prolong the <i>in Vivo</i> Half-Life of a Nanomolar EphA4 Receptor Antagonist
Maricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Nature Communications
|
June 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling
Michael J Roy, Minglyanna G Surudoi, Ashleigh Kropp, et al.
Redox Biology
|
December 6, 2022
Design and characterization of a heterobifunctional degrader of KEAP1
Hao Chen, Nghi H Nguyen, Charlene M Magtoto, et al.
Nature
|
April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissues
Marco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Frontiers in Chemistry
|
May 2, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
Dale J Calleja, Nathan Kuchel, Bernadine G C Lu, et al.
Page
of 4